ACTH(4-7)-Derived Heptapeptide
Semax is an ACTH(4-7)-derived heptapeptide with a C-terminal Pro-Gly-Pro sequence, represented as Met-Glu-His-Phe-Pro-Gly-Pro in peptide literature.
Product Procurement
Research-use catalog items with clear ordering, product context, and documentation support.
Semax – 10mg
$34.99
Product estimate
- FORMAT
- Lyophilized Powder
- NET VIAL CONTENT
- 10mg
- CATEGORY
- Peptides
- SKU
- ALS-SEMAX-10MG
Out of stock
Research Use Notice
For laboratory research use only. Not for human or veterinary use, food, drug, cosmetic, or household use.
Product Intelligence
Semax Peptide Profile
ACTH(4-7)-derived regulatory heptapeptide research material supplied as 10mg lyophilized Semax.
10mg Lyophilized Material
This catalog entry identifies a 10mg lyophilized presentation. Form-specific identity and lot details should be confirmed against the product and lot documentation supplied through Standards.
Regulatory-Peptide Chemistry Models
Semax appears in laboratory literature involving regulatory-peptide chemistry, peptide-metal coordination, cell-based assays, and peptide-signaling models. This context is limited to research classification.
- ClassRegulatory heptapeptide
- SequenceMet-Glu-His-Phe-Pro-Gly-Pro
- IdentifierPubChem CID 9811102
- Presentation10mg lyophilized material
Documentation
Verification & Documentation
Documentation is handled by product and lot. Use Standards to search for a matching record; if none appears, contact support with the product name, SKU, and lot number.